Ives Jeffrey L. 4
4 · Cara Therapeutics, Inc. · Filed Jun 5, 2023
Insider Transaction Report
Form 4
Ives Jeffrey L.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-01+44,961→ 44,961 totalExercise: $3.09Exp: 2033-06-01→ Common Stock (44,961 underlying) - Award
Common Stock
2023-06-01+32,362→ 47,838 total
Footnotes (2)
- [F1]Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of (i) June 1, 2024 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.
- [F2]This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 1, 2024 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.